CIK 0001935979
- Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- Operating
- Phone
- +1 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- 4 Open-market buy Director bought 29,000 shares at $35.94 ($1,042,393)
- 4 Open-market buy Director bought 21,052 shares at $47.50 ($999,970)
- 4 Open-market buy Chief Executive Officer bought 21,052 shares at $47.50 ($999,970)
- 4 Open-market buy Director bought 5,000 shares at $44.19 ($220,966)
- 4 Open-market buy Director bought 28,400 shares at $35.67 ($1,012,983)
- 4 Open-market buy Chief Scientific Officer bought 30,000 shares at $33.58 ($1,007,490)
- 4 Open-market buy Director bought 28,000 shares at $35.58 ($996,240)
- 4 Open-market buy Director bought 15,000 shares at $34.19 ($512,877)
- 4 Open-market buy Director bought 28,500 shares at $35.17 ($1,002,470)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 25,503 shares at $39.18 ($999,169)
- 4 Open-market buy Director bought 48,780 shares at $41.00 ($1,999,980)
- 4 Open-market buy Director bought 195,121 shares at $41.00 ($7,999,961)
- 4 Open-market buy Chief Executive Officer bought 121,951 shares at $41.00 ($4,999,991)
Page 3 of 7 · 130 filings